TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,406,000 | -49.2% | 65,474 | -73.9% | 0.20% | -59.2% |
| Q3 2020 | $6,700,000 | -50.6% | 250,401 | -64.0% | 0.50% | -41.9% |
| Q2 2020 | $13,566,000 | +400.8% | 696,390 | +153.0% | 0.86% | +240.6% |
| Q1 2020 | $2,709,000 | -69.9% | 275,305 | -66.1% | 0.25% | -61.3% |
| Q4 2019 | $9,006,000 | -7.5% | 811,292 | -53.2% | 0.65% | -26.2% |
| Q3 2019 | $9,734,000 | -10.8% | 1,733,628 | +37.4% | 0.88% | -12.3% |
| Q2 2019 | $10,911,000 | +285.7% | 1,261,384 | +258.5% | 1.00% | +267.4% |
| Q1 2019 | $2,829,000 | – | 351,811 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |